Paraneoplastic neurologic disorders in children

Current Neurology and Neuroscience Reports

Volumn 11, Issue 2, 2011, Pages 187-194

  Wells, Elizabeth M ^a   Dalmau, Josep ^b  

^a CHILDREN'S NATIONAL MEDICAL CENTER   (United States)

^b UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

Children; Limbic encephalitis; NMDA receptor encephalitis; Opsoclonus myoclonus; Paraneoplastic

Indexed keywords

(3 IODOBENZYL)GUANIDINE; CANCER ANTIBODY; CORTICOSTEROID; CORTICOTROPIN; CYCLOPHOSPHAMIDE; DEXAMETHASONE; FLUORODEOXYGLUCOSE; HU ANTIBODY; IMMUNOGLOBULIN; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; N METHYL DEXTRO ASPARTIC ACID RECEPTOR ANTIBODY; PREDNISONE; RECEPTOR ANTIBODY; RITUXIMAB; UNCLASSIFIED DRUG;

BEHAVIOR DISORDER; CANCER DIAGNOSIS; CANCER IMMUNOTHERAPY; CEREBELLUM DEGENERATION; CHILD; COGNITIVE DEFECT; COMPUTER ASSISTED TOMOGRAPHY; DERMATOMYOSITIS; DISEASE ASSOCIATION; DRUG MEGADOSE; EATON LAMBERT SYNDROME; ELECTROENCEPHALOGRAM; HODGKIN DISEASE; HORNER SYNDROME; HUMAN; IMMUNE RESPONSE; IMMUNOPATHOGENESIS; IMMUNOSUPPRESSIVE TREATMENT; LANGUAGE DISABILITY; MENTAL DISEASE; MOTOR DYSFUNCTION; MYASTHENIA GRAVIS; N METHYL DEXTRO ASPARTIC ACID RECEPTOR ANTIBODY ENCEPHALITIS; NEUROBLASTOMA; NEUROLOGIC DISEASE; NUCLEAR MAGNETIC RESONANCE IMAGING; OPSOCLONUS MYOCLONUS SYNDROME; PARANEOPLASTIC NEUROPATHY; PATHOPHYSIOLOGY; PLASMAPHERESIS; POLYMYOSITIS; REVIEW; THYMOMA; WHOLE BODY PET;

ADULT; CHILD; HUMANS; LIMBIC ENCEPHALITIS; OPSOCLONUS-MYOCLONUS SYNDROME; PARANEOPLASTIC SYNDROMES, NERVOUS SYSTEM; RECEPTORS, N-METHYL-D-ASPARTATE;

EID: 79955830796     PISSN: 15284042     EISSN: None     Source Type: Journal    
DOI: 10.1007/s11910-010-0169-4     Document Type: Review

References (52)

1. Dalmau J, Rosenfeld MR: Paraneoplastic syndromes of the CNS. Lancet Neurol. 2008 Apr;7(4):327-40. This article reviews classic concepts about paraneoplastic neurologic disorders and recent clinical and immunologic developments.
2. Posner JB: Paraneoplastic opsoclonus/myoclonus: B cells, T cells, both, or neither? Neurology. 2004 May 11;62(9):1466-7.
3. Sommer C, Weishaupt A, Brinkhoff J, et al.: Paraneoplastic stiff-person syndrome: passive transfer to rats by means of IgG antibodies to amphiphysin. Lancet. 2005 Apr 16-22;365(9468):1406-11. (Pubitemid 40523735)
4. Graus F, Delattre JY, Antoine JC, et al.: Recommended diagnostic criteria for paraneoplastic neurological syndromes. J Neurol Neurosurg Psychiatry. 2004 Aug;75(8):1135-40. (Pubitemid 39005770)
5. Turkel SB, Brumm VL, Mitchell WG, et al.: Mood and behavioral dysfunction with opsoclonus-myoclonus ataxia. J Neuropsychiatry Clin Neurosci. 2006 Spring;18(2):239-41.
6. Pang KK, de Sousa C, Lang B, et al.: A prospective study of the presentation and management of dancing eye syndrome/opsoclonus- myoclonussyndrome in the United Kingdom. Eur J Paediatr Neurol. 2010 Mar;14(2):156-61. Epub 2009 May 6.
7. Pohl KR, Pritchard J, Wilson J: Neurological sequelae of the dancing eye syndrome. Eur J Pediatr. 1996 Mar;155(3):237-44. (Pubitemid 26053363)
8. Younes-Mhenni S, Janier MF, Cinotti L, et al.: FDG-PET improves tumour detection in patients with paraneoplastic neurological syndromes. Brain. 2004 Oct;127(Pt 10):2331-8. Epub 2004 Sep 10 (Pubitemid 39382241)
9. Linke R, Schroeder M, Helmberger T, Voltz R: Antibody-positive paraneoplastic neurologic syndromes: value of CT and PET for tumor diagnosis. Neurology. 2004 Jul 27;63(2):282-6. (Pubitemid 38971127)
10. Titulaer MJ, Soffietti R, Dalmau J, et al.: Screening for tumours in paraneoplastic syndromes: report of an EFNS Task Force. Eur J Neurol. 2010 Sep 29.
11. Kushner BH, Kramer K, Modak S, et al.: Sensitivity of surveillance studies for detecting asymptomatic and unsuspected relapse of high-risk neuroblastoma. J Clin Oncol. 2009 Mar 1;27(7):1041-6. Epub 2009 Jan 26.
12. McGarvey CK, Applegate K, Lee ND, Sokol DK: False-positive metaiodobenzylguanidine scan for neuroblastoma in a child with opsoclonus-myoclonus syndrome treated with adrenocorticotropic hormone (ACTH). J Child Neurol. 2006 Jul;21(7):606-10. (Pubitemid 44295145)
13. Swart JF, de Kraker J, van der Lely N: Metaiodobenzylguanidine total-body scintigraphy required for revealing occult neuroblastoma in opsoclonus-myoclonus syndrome. Eur J Pediatr. 2002 May;161(5):255-8. Epub 2002 Mar 13. (Pubitemid 34492684)
14. Blaes F, Pike MG, Lang B: Autoantibodies in childhood opsoclonus-myoclonus syndrome. J Neuroimmunol. 2008 Sep 15;201-202:221-6. Epub 2008 Aug 6.
15. van Vuurden DG, Plötz FB, de Jong M, et al.: Therapeutic total plasma exchange in a child with neuroblastoma-related anti-Hu syndrome. Pediatr Nephrol. 2005 Nov;20(11):1655-6. Epub 2005 Aug 24. (Pubitemid 41554484)
16. Tate ED, Allison TJ, Pranzatelli MR, et al.: Neuroepidemiologic trends in 105 US cases of pediatric opsoclonus-myoclonus syndrome. J Pediatr Oncol Nurs. 2005 Jan-Feb;22(1):8-19. (Pubitemid 40091116)
17. Raffaghello L, Conte M, De Grandis E, Pistoia V: Immunological mechanisms in opsoclonus-myoclonus associated neuroblastoma. European Journal of Paediatric Neurology 2009;13(3):219-23.
18. Fühlhuber V, Bick S, Kirsten A, et al.: Elevated B-cell activating factor BAFF, but not APRIL, correlates with CSF cerebellar autoantibodies in pediatric opsoclonus-myoclonus syndrome. J Neuroimmunol. 2009 May 29;210(1-2):87-91. Epub 2009 Mar 31.
19. Pranzatelli MR, Tate ED, Hoefgen ER, et al.: Therapeutic down-regulation of central and peripheral B-cell-activating factor (BAFF) production in pediatric opsoclonus-myoclonus syndrome. Cytokine. 2008 Oct;44(1):26-32. Epub 2008 Aug 9.
20. Krasenbrink I, Fühlhuber V, Juhasz-Boess I, et al.: Increased prevalence of autoimmune disorders and autoantibodies in parents of children with opsoclonus-myoclonus syndrome (OMS). Neuropediatrics. 2007 Jun;38(3):114-6. (Pubitemid 350195625)
21. Kirsten A, Beck S, Fühlhuber V, et al.: New autoantibodies in pediatric opsoclonus myoclonus syndrome. Ann N Y Acad Sci. 2007 Sep;1110:256-60 (Pubitemid 350043014)
22. Sabater L, Xifró X, Saiz A, et al.: Analysis of antibodies to neuronal surface antigens in adult opsoclonus-myoclonus. J Neuroimmunol 2008;196:188-91
23. Ertle F, Behnisch W, Al Mulla NA, et al.: Treatment of neuroblastoma-related opsoclonus-myoclonus-ataxia syndrome with high-dose dexamethasone pulses. Pediatr Blood Cancer. 2008 Mar;50(3):683-7. (Pubitemid 351155860)
24. Pranzatelli MR, Tate ED, Swan JA, et al.: B cell depletion therapy for new-onset opsoclonus-myoclonus. Mov Disord. 2010 Jan 30;25(2):238-42. Authors report that the combination of rituximab with conventional agents as initial therapy was effective and safe in 12 patients.
25. De Grandis E, Parodi S, Conte M, et al.: Long-term follow-up of neuroblastoma-associated opsoclonus-myoclonus-ataxia syndrome. Neuropediatrics. 2009 Jun;40(3):103-11. Epub 2009 Dec 17.
26. Pranzatelli MR, Tate ED, Dukart WS, et al.: Sleep disturbance and rage attacks in opsoclonus-myoclonus syndrome: response to trazodone. J Pediatr. 2005 Sep;147(3):372-8. (Pubitemid 41345769)
27. Koh PS, Raffensperger JG, Berry S, et al.: Long-term outcome in children with opsoclonus-myoclonus and ataxia and coincident neuroblastoma. J Pediatr. 1994 Nov;125(5 Pt 1):712-6. (Pubitemid 24350179)
28. Schmahmann JD: Neuropsychol Rev. 2010 Sep;20(3):236-60. Epub 2010 Sep 7.
29. Wells EM, Walsh KS, Khademian ZP, et al.: The cerebellar mutism syndrome and its relation to cerebellar cognitive function and the cerebellar cognitive affective disorder. Dev Disabil Res Rev. 2008;14(3):221-8.
30. Haberlandt E, Bast T, Ebner A, et al.: Limbic encephalitis in children and adolescents. Arch Dis Child. 2010 Oct 19.
31. Yeung WL, Li CK, Nelson EA, et al.: Unusual neurological presentation of neuroblastoma. Hong Kong Med J. 2003 Apr;9(2):142-4. (Pubitemid 36406700)
32. Gultekin SH, Rosenfeld MR, Voltz R, et al.: Paraneoplastic limbic encephalitis: neurological symptoms, immunological findings and tumour association in 50 patients. Brain. 2000 Jul;123 (Pt 7):1481-94. (Pubitemid 30420947)
33. Vedeler CA, Antoine JC, Giometto B, et al.: Paraneoplastic Neurological Syndrome Euronetwork. Management of paraneoplastic neurological syndromes: report of an EFNS Task Force. Eur J Neurol. 2006 Jul;13(7):682-90 (Pubitemid 44139368)
34. Graus F, Cordon-Cardo C, Posner J: Neuronal antinuclear antibodyin sensory neuronopathy from lung cancer. Neurology 1985;35:538-543. (Pubitemid 15085073)
35. Graus F, Elkon KB, Cordon-Cardo C, et al.: Sensory neuronopathy and small cell lung cancer; antineuronal antibody that also reacts with the tumor. Am J Med 1986;80:45-52. (Pubitemid 16134802)
36. Dalmau J, Graus F, Rosenblum MK, et al.: Anti-Hu associated paraneoplastic encephalomyelitis/sensory neuropathy: a clinical study of 71 patients. Medicine (Baltimore) 1992, 71(2):59-72.
37. Darnell RB: NMDA receptor as a target in paraneoplastic encephalitis. Ann Neurol. 2007 Jan;61(1):3-4.
38. Dalmau J, Tüzün E, Wu H-Y, et al.: Paraneoplastic anti-N-methyl-D-aspartate receptor encephalitis associated with ovarian teratoma. Ann Neurol 2007;61:25-36. This is the first report of the identification of antibodies against NR1/2 heteromers of the NMDAR.
39. Dalmau J, Gleichman AJ, Hughes EG, et al.: Anti-NMDA receptor encephalitis: case series and analysis of the effects of antibodies. Lancet Neurol 2008;7:1091-1098. Based in a study of 100 patients, this article reports the syndrome and immunological findings that characterize anti-NMDAR encephalitis.
40. Florance NR, Davis RL, Lam C, et al.: Anti-N-methyl-D-aspartate receptor (NMDAR) encephalitis in children and adolescents. 2009 Jul;66(1):11-8. This article characterizes a large sample of children with this relatively newly discovered condition that is increasingly recognized in children.
41. Hughes EG, Peng X, Gleichman AJ, et al.: Cellular and synaptic mechanisms of anti-NMDA receptor encephalitis. J Neurosci. 2010 Apr 28;30(17):5866-75.
42. Lebas A, Husson B, Didelot A, et al.: Expanding spectrum of encephalitis with NMDA receptor antibodies in young children.J Child Neurol. 2010 Jun;25(6):742-5. Epub 2009 Oct 15. This article presents young cases of paraneoplastic encephalitis with NMDA antibodies including the first known case associated with neuroblastoma.
43. Lesher AP, Myers TJ, Tecklenburg F, et al.: Anti-N-methyl-D-aspartate receptor encephalitis associated with an ovarian teratoma in an adolescent female. J Pediatr Surg. 2010 Jul;45(7):1550-3.
44. Sonn TS, Merritt DF: Anti-NMDA-receptor encephalitis: an adolescent with an ovarian teratoma. J Pediatr Adolesc Gynecol. 2010 Oct;23(5):e141-4.
45. Sillevis-Smitt P, Grefkens J, de LeeuwB, et al.: Survival and outcome in 73 anti-Hu positive patientswith paraneoplastic encephalomyelitis/sensory neuronopathy. J Neurol 2002;249:745-753.
46. Shams'ili S, de Beukelaar J, Gratama JW, et al.: An uncontrolled trial of rituximab for antibody associated paraneoplastic neurological syndromes. J Neurol. 2006 Jan;253(1):16-20.
47. Iizuka T, Yoshii S, Kan S, et al.: Reversible brain atrophy in anti-NMDA receptor encephalitis: a long-term observational study. J Neurol. 2010 Oct;257(10):1686-91. Epub 2010 Jun 2.
48. Drukker CA, Heij HA, Wijnaendts LC, et al.: Paraneoplastic gastro-intestinal anti-Hu syndrome in neuroblastoma. Pediatr Blood Cancer. 2009 Mar;52(3):396-8.
49. Emir S, Kutluk MT, Gö?ü? S, et al.: Paraneoplastic cerebellar degeneration and Horner syndrome: association of two uncommon findings in a child with Hodgkin disease. J Pediatr Hematol Oncol. 2000 Mar-Apr;22(2):158-61. (Pubitemid 32290153)
50. de Buys Roessingh AS, Loriot MH, Wiesenauer C, et al.: Lambert-Eaton myasthenic syndrome revealing an abdominal neuroblastoma. Pediatr Surg. 2009 Aug;44(8):E5-7.
51. Ghosh JB, Roy M, Peters T: Thymoma associated with myasthenia gravis in infancy. Indian J Pediatr. 2009 Oct;76(10):1057-8. Epub 2009 Nov 12.
52. Morris P, Dare J: Juvenile dermatomyositis as a paraneoplastic phenomenon: an update. J Pediatr Hematol Oncol. 2010 Apr;32(3):189-91.